AlAli, F.; Alahmdi, A.; Nasiri, A.; Rasheed, W.; Alotaibi, A. S.; Almahayni, M. H.; Shaheen, M.; Elhassan, T.; Alothaimeen, H.; Alfayez, M.; AlAhmari, A.; Alkhaldi, H.; Albanyan, O.; Hashmi, S.; Chaudhri, N.; Khalil, S.; AlSharif, F.; Mohamed, S. Y.; Alfraih, F.; AbaAlkhail, H.; Ahmed, S.; ElGohary, G.; Hussein, T.; Abdrabou, A. K.; Adam, A.; Saleh, M.; Slaman, A. B.; Nassani, M.; Bajuaifer, Y.; Madien, H.; Ahmed, S.; Alfaqaawi, S.; Benlamine, C.; Ali, L.; Nassar, M.; Aleid, M.; Alzaidy, N.; ElFakih, R.; Saad, A.; Hanbali, A.; Alzahrani, H.; Aljurf, M.; Almohareb, F.; Ahmed, S. O. Higher Relapse Rate and Resource Utilization With Ara-C Consolidation Chemotherapy Alone Compared to Hematopoietic Cell Transplantation in First Remission in a Cohort of Younger Adults With Acute Myeloid Leukemia With t(8;21) (q22;Q22.1). J Hematol 2026, 15 (5), 236-247. https://doi.org/10.14740/jh2203.